InterMune (ITMN)

Add to Watchlists Create an Alert
73.48 +0.04  +0.05% NASDAQ Sep 2, 1:33PM BATS Real time Currency in USD
View Full Chart
ITMN Price Chart
View All Events

ITMN Events

Date Type Description
08/06/2014 13:30 PDT Misc Q2 2014 InterMune Earnings Conference Call
08/06/2014 Earnings Q2 2014 InterMune Earnings Results
05/29/2014 Misc Annual General Meeting for InterMune Inc
05/01/2014 16:30 EDT Misc Q1 2014 Intermune Earnings Conference Call
05/01/2014 Earnings Q1 2014 Intermune Earnings Results
02/25/2014 08:00 EST Misc InterMune, Inc. Q4 2013 Earnings Conference Call
02/25/2014 Earnings InterMune, Inc. Q4 2013 Earnings Results
10/30/2013 16:30 EDT Earnings Intermune to Release Third Quarter Financial Results
10/30/2013 16:30 EDT Misc Q3 2013 Intermune Earnings Conference Call
View All Performance Charts

ITMN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). InterMune is up 393.2% over the last year vs S&P 500 Total Return up 24.37%, Gilead Sciences up 78.98%, and Roche Holding up 19.22%.

Get Quote for

PDF Report for ITMN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ITMN Pro Report PDF
Advertisement

Portfolio Strategies Featuring ITMN

Did InterMune make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ITMN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.intermune.com
  • IR Website: http://phx.corporate-ir.net/phoenix.zhtml?c=100067&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.

ITMN Excel Add-In Codes

  • Name: =YCI("ITMN","name")
  • Description: =YCI("ITMN","description")
  • Sector: =YCI("ITMN","sector")
  • Industry: =YCI("ITMN","industry")
  • Est. Current Fiscal Year End: =YCI("ITMN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.